Hady Lichaa, MD
Cardiovascular Disease · Murfreesboro, TNNPI 1336267533
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (39.6%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. It is spread thinly across 45 manufacturers, the largest accounting for just 18.7%. Among cardiovascular disease clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 285 payments — averaging $330.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abiomed$18K
- Bard Peripheral Vascular, Inc.$15K
- Cordis US CORP.$10K
- Surmodics, Inc.$10K
- Shockwave Medical, Inc$10K
- Philips North America LLC$7K
- plus $24K from 39 others
What the payments were for
- Consulting fees$37,23840%
- Speaking & faculty fees$30,50032%
- Travel & lodging$10,31011%
- Food & beverage$15,93017%
- Education$780%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Impella$17,043
- LUTONIX$14,500
- Pounce Thrombectomy System$9,598
- Pounce Venous Thrombectomy System$9,598
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$9,041
- Pounce Thrombectomy$8,418
- (6554) Peripheral Vascular Undivided$5,635
- Indigo System$4,123
- OPTIS$2,875
- Abre$2,818
- ACCOLADE SR$2,188
- Diamondback Peripheral$2,000
- (9520) IGT Devices Undivided$1,100
- RAILWAY$800
- Sublime 014 Rx PTA Balloon Dilatation Catheter$696
- Sublime Microcatheter, 018, 200cm, Straight$696
- Aggrastat (tirofiban HCl)$600
- TurboHawk$439
- SUPER TORQUE$400
- RAIN SHEATH TRANSRADIAL$400
How this compares
$94,055 in reported general payments places this provider in the 95th percentile of 429 cardiovascular disease providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 224 | $216,302 |
| XareltoRivaroxaban | 174 | $150,622 |
| FarxigaDapagliflozin Propanediol | 91 | $76,372 |
| EntrestoSacubitril/Valsartan | 66 | $63,745 |
| Repatha SureclickEvolocumab | 100 | $61,139 |
| BrilintaTicagrelor | 48 | $33,699 |
| JardianceEmpagliflozin | 37 | $30,766 |
| MultaqDronedarone Hcl | 16 | $22,492 |
| Ranolazine ErRanolazine | 203 | $19,731 |
| Icosapent Ethyl | 61 | $15,101 |
| KerendiaFinerenone | 18 | $14,999 |
| VascepaIcosapent Ethyl | 18 | $12,462 |
| OzempicSemaglutide | 12 | $11,189 |
| Enoxaparin Sodium | 14 | $8,899 |
| Atorvastatin Calcium | 532 | $6,802 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $34 | $216,302224 claims |
| Johnson & JohnsonXarelto | $457 | $150,622174 claims |
| AstraZenecaFarxiga, Brilinta | $122 | $110,071139 claims |
| NovartisEntresto | $44 | $63,74566 claims |
| Boehringer IngelheimJardiance | $28 | $30,76637 claims |
| Novo NordiskOzempic | $129 | $11,18912 claims |
| Lexicon Pharmaceuticals, Inc.Inpefa | $33 | $6,27311 claims |
| Esperion Therapeutics, Inc.Nexletol | $43 | $4,51712 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 429 cardiovascular disease providers in Tennessee.
Other cardiovascular disease in Murfreesboro
- David MetzgerKingsport$555K
- Christopher EllisNashville$527K
- Joann LindenfeldNashville$270K
- Steven GubinMemphis$248K
- Andrew ZurickNashville$231K
- Mark ZenkerNashville$225K
- Selcuk TombulChattanooga$198K
- George CrossleyNashville$197K
- Joel PharesNashville$171K
- Arvindh KanagasundramNashville$161K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.